Individual Susceptibility To Ephedrine Alkaloid AEs Cited By FDA Consultants
This article was originally published in The Tan Sheet
Executive Summary
Additional research would help determine whether certain individuals have enhanced sensitivity to the effects of ephedrine alkaloids, consultants retained by FDA to review adverse event reports involving the dietary supplement ingredient suggest.
You may also be interested in...
Ephedra Cardiovascular Side Effects "Minimal" - Columbia/Harvard Study
Ephedra/caffeine combination weight-loss supplements caused "minimal" cardiovascular side effects in a Columbia University/Harvard University clinical trial, researchers reported at the North American Association for the Study of Obesity annual scientific meeting in Long Beach, Calif.
Ephedrine Alkaloid Products Linked To AERs In 78% Of Cases - CDER
The number of ephedrine alkaloid-containing dietary supplements available for sale in the U.S. has more than tripled during the last five years, a Center for Food Safety & Applied Nutrition survey finds.
Ephedrine Alkaloid Weight-Loss Claims Proposed Ban Lifted By FDA
FDA is withdrawing a proposed prohibition on claims that promote long-term use of ephedrine alkaloid-containing dietary supplements, such as claims for weight loss and bodybuilding.